Business

Biotech Industry at BIO 2026 Conference

Updated 2026-06-25 19:25 UTC 1 source Neutral

Executives from the biotech industry discussed concerns over Chinese competition, AI technology, and drug pricing policies at the BIO 2026 conference.

Coverage timeline — 1 article

STAT News

STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better

Biotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.

2026-06-25 19:19 UTC